YBX3 and nonpapillary renal cell carcinoma: Additionally, compared with the matched paracancerous samples (n = 72), a significantly high expression level of YBX3 was identified in ccRCC samples (n = 72, P = 4.28e-23, 95% CI: 1.3737–1.8079) (Fig. 1C).